Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
UBC provides a consultative approach to building protocol-specific, virtual evidence generation strategies through comprehensive decentralized solutions.
Explore NexusPartnering with the biopharmaceutical industry to provide leading late stage and patient support services focused on patient safety, access, and value.
Real Data
Real People
Real Outcomes
Our customizable and innovative tools enhance UBC’s Global Late Stage, Safety, and Patient Support Services focusing on patient safety, data security, efficiency, quality, and product value.
Learn MoreArticle | January 12, 2021
UBC is proud to be a founding member of the DTRA and accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
Read MoreArticle | February 17, 2021
UBC is announcing an offering to harness the power of real-world data (RWD) for rapid generation of insights into the safety and effectiveness of COVID-19 vaccines.
Read MoreArticle | January 22, 2021
According to UBC’s Ron Lacy VP, Products & Innovation, “Where we have deployed this technology, we are seeing 95% positive patient sentiment in response to the inclusion of mobile messaging in the patient’s therapy journey, along with improved patient outcomes."
Read MoreIf you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below. For all other general inquires please message: contact@ubc.com
* required field
If you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below.For all other general inquires please message: contact@ubc.com
* required field